-Reuters
Barclays Maintains Equal-Weight on UiPath, Lowers Price Target to $70
Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Equal-Weight and lowers the price target from $73 to $70.
Related Posts
REITs: Healthcare Or Office? One Performs Better In A Recession (Both Tout Yields Over 5%)
From data gathered on Sept. 30, 2019, healthcare real estate investment trusts (REITs) have earned a trailing ten-year return of 11.6% on average.
Office REITs, however, tend to have an average ten-year return of 9%.
Wabash National Q2 EPS $0.46 Beats $0.45 Estimate, Sales $642.80M Beat $603.15M Estimate
Wabash National (NYSE:WNC) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.45 by 2.22 percent. This is a 119.05 percent increase over earnings of $0.21 per share from the
SRM Entertainment Files S-1 Registration For Spin-Off From Jupiter Wellness; Jupiter Wellness Shareholders To Receive Distribution Of Shares In A Nasdaq-Listed SRM Entertainment
Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair, skin, and sexual wellness, announced today that SRM Entertainment, Inc. (SRM) has filed a registration statement with the Securities and Exchange